Mylan Receives FDA Approval For Generic Version Of Prevacid® Through Its Subsidiary Matrix Laboratories
Links shared publicly online about this topic.
- 1,608total visits
Mylan Receives FDA Approval For Generic Version Of Prevacid® Through Its Subsidiary Matrix Laboratories
View full resource at medicalnewstoday.com
Tags: Heartburn Medication, H pylori Infection Medication, Erosive Esophagitis Medication, Stomach Ulcer Medication, Duodenal Ulcer Medication, Drug, FDA, Prevacid
Most Recently Shared on November 12, 2009 at 1:39 pm By:
Mylan Receives FDA Approval For Generic Version Of Prevacid® Through Its Subsidiary Matrix Laboratories: Mylan .. http://bit.ly/8dj9q
Mylan Receives Approval for Generic Boniva - MPR
empr.com — “Mylan announced that the FDA has approved Ibandronate Sodium 150mg tablets, the generic version of Roche’s Boniva.” View full resource at empr.com
Most Recently Shared on March 20, 2012 at 2:07 pm By:
Mylan Receives Approval for #Generic #Boniva #osteoporosis #pharmacist http://t.co/VyL338bx
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on February 13, 2012 at 4:30 pm By:
PharmaLive Pharma and Health News
#Mylan Receives Final #FDA Approval for First Generic Version of #Doryx http://t.co/AdZTehtf
Mylan Receives Approval For Generic Version Of Effexor XR® Capsules
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applicat” View full resource at medicalnewstoday.com
Most Recently Shared on June 3, 2011 at 7:05 am By:
MNT Drug Approvals Health News
Mylan Receives Approval For Generic Version Of Effexor XR® Capsules http://mnt.to/3WHx #regulatory
Mylan gets FDA approval for generic Neurontin - BusinessWeek
businessweek.com — “Mylan Inc. said Monday its Matrix Laboratories unit received Food and Drug Administration approval to market a generic version of Pfizer Inc.'s drug Neurontin.” View full resource at businessweek.com
Most Recently Shared on March 2, 2011 at 4:56 pm By:
Physician Assistants Health News Feed
Generic Neurontin, gabapentin, approved for seizures, shingles pain, nerve pain: http://www.businessweek.com/ap/financialnews/D9LLV4JO0.htm
FDA approves Mylan's generic Adalat CC Tablets ANDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Bayer's Adalat® CC Tablets, a treatment for hypertension.” View full resource at news-medical.net
Most Recently Shared on December 10, 2010 at 1:24 pm By:
FDA approves Mylan's generic Adalat CC Tablets ANDA: Mylan Inc. today announced that its subsidiary Mylan Pharma... http://bit.ly/eHxFHX
Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets
news-medical.net — “Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex Tablets, a Parkinson's disease treatment.” View full resource at news-medical.net
Most Recently Shared on October 21, 2010 at 4:13 pm By:
Parkinson's Disease: Mylan receives final FDA approval for Pramipexole Dihydrochloride Tablets: Mylan Inc. today a... http://bit.ly/azUuAK
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Generic Version Of Reyataz® Capsules HIV Treatment
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 3:05 pm By:
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Generic Version Of Reyataz® Capsules HIV Treatment http://mnt.to/3KPw
Mylan Receives Approval For Generic Version Of Prograf® Capsules
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applic” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2010 at 5:05 pm By:
MNT Transplants News Health News
Mylan Receives Approval For Generic Version Of Prograf® Capsules http://mnt.to/3K95 #transplants
Mylan Announces Approval Under PEPFAR For Generic Version Of Videx(R) EC HIV Treatment
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan” View full resource at medicalnewstoday.com
Most Recently Shared on April 22, 2010 at 2:09 pm By:
Mylan Announces Approval Under PEPFAR For Generic Version Of Videx(R) EC HIV Treatment http://mnt.to/3BBw #hivaids
Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.” View full resource at news-medical.net
Most Recently Shared on April 19, 2010 at 1:35 pm By:
Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR: Mylan Inc. t... http://bit.ly/cxh5Cs
Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval
news-medical.net — “Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.” View full resource at news-medical.net
Most Recently Shared on April 12, 2010 at 5:26 pm By:
Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval: Mylan Inc. today announced that... http://bit.ly/cAMf63
Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)
news.prnewswire.com — “Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)” View full resource at news.prnewswire.com
Most Recently Shared on August 10, 2009 at 11:09 pm By:
Stephen Roberts, MD Physician and Doctor
"Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)" http://bit.ly/19kuQT
Pharmaceutical News - Topix
topix.net — “Pharmaceuticals news continually updated from thousands of sources around the net.” View full resource at topix.net
Most Recently Shared on July 17, 2009 at 1:41 pm By:
eyeonfda Pharma and Health Lawyer
Mylan Receives FDA Approval For Generic Version Of Thyroid Deficiency Treatment Cytomel http://bit.ly/16vZ7e
Mylan gets tentative FDA OK for generic Singulair - MarketWatch
marketwatch.com — “NEW YORK (MarketWatch) -- Mylan Inc. said Friday that it has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for a generic version of Merck & Co.'s Singulair. Mylan said that the same strength of Singular, an allergy and asthma drug, had total U.S. sales of about $2.6 billion in the year ended March 31, according to IMS Health.” View full resource at marketwatch.com
Most Recently Shared on May 29, 2009 at 1:05 pm By:
eyeonfda Pharma and Health Lawyer
Mylan gets tentative FDA OK for generic Singulair http://bit.ly/9c5JI
Advertisement
